In 2012, the revenue volume of the Turkish healthcare market ranked 6th in Europe and 16th worldwide. The sales volume of the pharmaceutical industry increased by 37% in the period from 2004 to 2012, from USD 6.2 billion to USD 8.6 billion.
In the last decade, the Turkish healthcare system has experienced the greatest transformation in its history. The success of healthcare reform, particularly the Health Transformation Programme, demonstrates a clear improvement of the healthcare system.
The programme of universal health insurance was introduced to guarantee every Turkish citizen the right to healthcare. As a result, the Social Security Institution has become the most important purchaser of healthcare services.
MGF-D PROJECTS IN THE HEALTHCARE SECTOR
Turkish clinic operators have a high demand for devices and instruments, most of which must be imported.
The Ministry of Health is now investing in the modernization of existing facilities and working together with private investors to construct municipal hospitals.
As a part of the agreement between these public-private sector partnerships, the hospitals are constructed or equipped by the investors and subsequently leased to publicly-owned operators.
Thirty-eight hospitals are planned for 2016. MGF-Development Turkey is currently accompanying some of the investors on their way to the next call for tenders for these projects.